 |
Previous Article | Next Article 
The Journal of Neuroscience, November 15, 2002, 22(22):9733-9741
Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model
of Alzheimer's Disease
Thomas
Fath1, 2,
Jochen
Eidenmüller2, and
Roland
Brandt1, 2
1 Department of Neurobiology, University of
Osnabrück, 49076 Osnabrück, Germany, and
2 Interdisziplinäres Zentrum für
Neurowissenschaften, Department of Neurobiology, University of
Heidelberg, 69120 Heidelberg, Germany
Aggregation and increased phosphorylation of tau at selected sites
("hyperphosphorylation") are histopathological hallmarks of
Alzheimer's disease (AD). However, it is not known whether the tau
pathology has a primary role during neuronal degeneration. To determine
the role of tau hyperphosphorylation in AD, pseudohyperphosphorylated tau (PHP-tau) that simulates disease-like permanent, high
stoichiometric tau phosphorylation and mimics structural and functional
aspects of hyperphosphorylated tau was expressed in neural cells. In
differentiated PC12 cells, PHP-tau exhibited reduced microtubule
interaction and failed to stabilize the microtubule network compared
with exogenously expressed wild-type tau (wt-tau). During longer
culture, PHP-tau exerted a cytotoxic effect, whereas wt-tau was
neutral. PHP-tau-mediated cytotoxicity was associated with an induction of apoptotic cell death as characterized by chromatin condensation, DNA
fragmentation, and caspase-3 activation in the absence of detectable
protein aggregates. Furthermore, PHP-tau expression specifically
sensitized the cells for other apoptotic stimuli (colchicine and
staurosporine). Herpes simplex virus-mediated overexpression of PHP-tau
induced degeneration associated with an induction of apoptotic
mechanisms also in terminally differentiated human CNS model neurons.
Partially pseudophosphorylated constructs caused an intermediate
toxicity. The data provide evidence for a neurotoxic "gain of
function" of soluble tau during AD as a result of structural changes
that are induced by a cumulative, high stoichiometric tau
phosphorylation. PHP-tau-expressing cells and organisms could provide a
useful system to identify mechanisms that contribute to tau-mediated toxicity.
Key words:
tau; Alzheimer's disease; phosphorylation; apoptosis; hyperphosphorylation; human model neurons
Copyright © 2002 Society for Neuroscience 0270-6474/02/22229733-09$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
F. Liu, J. Shi, H. Tanimukai, J. Gu, J. Gu, I. Grundke-Iqbal, K. Iqbal, and C.-X. Gong
Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
Brain,
July 1, 2009;
132(7):
1820 - 1832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-L. Li, H.-H. Wang, S.-J. Liu, Y.-Q. Deng, Y.-J. Zhang, Q. Tian, X.-C. Wang, X.-Q. Chen, Y. Yang, J.-Y. Zhang, et al.
Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration
PNAS,
February 27, 2007;
104(9):
3591 - 3596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ding, T. A. Matthews, and G. V. W. Johnson
Site-specific Phosphorylation and Caspase Cleavage Differentially Impact Tau-Microtubule Interactions and Tau Aggregation
J. Biol. Chem.,
July 14, 2006;
281(28):
19107 - 19114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shahani, S. Subramaniam, T. Wolf, C. Tackenberg, and R. Brandt
Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices.
J. Neurosci.,
May 31, 2006;
26(22):
6103 - 6114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cripps, S. N. Thomas, Y. Jeng, F. Yang, P. Davies, and A. J. Yang
Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation
J. Biol. Chem.,
April 21, 2006;
281(16):
10825 - 10838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Amadoro, M. T. Ciotti, M. Costanzi, V. Cestari, P. Calissano, and N. Canu
From the Cover: NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
PNAS,
February 21, 2006;
103(8):
2892 - 2897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Necula and J. Kuret
Pseudophosphorylation and Glycation of Tau Protein Enhance but Do Not Trigger Fibrillization in Vitro
J. Biol. Chem.,
November 26, 2004;
279(48):
49694 - 49703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. V. W. Johnson and W. H. Stoothoff
Tau phosphorylation in neuronal cell function and dysfunction
J. Cell Sci.,
November 15, 2004;
117(24):
5721 - 5729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. d. C. Alonso, A. Mederlyova, M. Novak, I. Grundke-Iqbal, and K. Iqbal
Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations
J. Biol. Chem.,
August 13, 2004;
279(33):
34873 - 34881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shimura, Y. Miura-Shimura, and K. S. Kosik
Binding of Tau to Heat Shock Protein 27 Leads to Decreased Concentration of Hyperphosphorylated Tau and Enhanced Cell Survival
J. Biol. Chem.,
April 23, 2004;
279(17):
17957 - 17962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ
Role of Tau Protein in Both Physiological and Pathological Conditions
Physiol Rev,
April 1, 2004;
84(2):
361 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Krishnamurthy and G. V. W. Johnson
Mutant (R406W) Human Tau Is Hyperphosphorylated and Does Not Efficiently Bind Microtubules in a Neuronal Cortical Cell Model
J. Biol. Chem.,
February 27, 2004;
279(9):
7893 - 7900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shimura, D. Schwartz, S. P. Gygi, and K. S. Kosik
CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival
J. Biol. Chem.,
February 6, 2004;
279(6):
4869 - 4876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cyr, J.-M. Beaulieu, A. Laakso, T. D. Sotnikova, W.-D. Yao, L. M. Bohn, R. R. Gainetdinov, and M. G. Caron
Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons
PNAS,
September 16, 2003;
100(19):
11035 - 11040.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|